SANGAMO THERAPEUTICS, INC (SGMO) Share-based Payment Arrangement, Expense USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sangamo Therapeutics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2024.
  • Sangamo Therapeutics, Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $2.72 M, a 67.2% decline year-over-year.
  • Sangamo Therapeutics, Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $21.8 M, a 32.4% decline year-over-year.
  • Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2023 was $27.4 M, a 13.5% decline from 2022.
  • Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $31.7 M, a 3.96% decline from 2021.
  • Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $33 M, a 28.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $21.8 M $2.72 M -$5.56 M -67.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $27.4 M $6.11 M -$2.14 M -26% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $29.5 M $6.19 M -$1.6 M -20.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $31.1 M $6.79 M -$1.13 M -14.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $32.2 M $8.28 M +$586 K +7.62% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $31.7 M $8.25 M +$172 K +2.13% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $31.5 M $7.79 M -$80 K -1.02% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $31.6 M $7.92 M -$1.57 M -16.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $33.1 M $7.69 M +$167 K +2.22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $33 M $8.08 M +$1.43 M +21.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $31.5 M $7.87 M +$1.19 M +17.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $30.3 M $9.48 M +$2.72 M +40.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $27.6 M $7.52 M +$1.9 M +33.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $25.7 M $6.64 M +$1.4 M +26.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $24.3 M $6.68 M +$1.98 M +42.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $22.3 M $6.76 M +$1.9 M +39% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $20.4 M $5.62 M +$1.1 M +24.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $19.3 M $5.24 M +$936 K +21.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $18.4 M $4.7 M +$891 K +23.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $17.5 M $4.87 M +$1.35 M +38.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $16.2 M $4.52 M +$1.47 M +48.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $14.7 M $4.3 M +$2.19 M +103% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $12.5 M $3.81 M +$1.59 M +71.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $10.9 M $3.51 M +$1.55 M +78.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $9.35 M $3.05 M +$262 K +9.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $9.09 M $2.12 M +$189 K +9.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $8.9 M $2.22 M -$516 K -18.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $9.42 M $1.96 M -$5.24 M -72.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $14.7 M $2.79 M -$406 K -12.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $15.1 M $1.93 M -$1.14 M -37.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $16.2 M $2.74 M -$93 K -3.29% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $16.3 M $7.2 M +$4.32 M +150% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $12 M $3.19 M +$241 K +8.16% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $11.7 M $3.07 M +$31 K +1.02% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $11.7 M $2.83 M +$699 K +32.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 $11 M $2.88 M +$754 K +35.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $10.2 M $2.95 M +$1.05 M +54.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $9.2 M $3.04 M +$987 K +48.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $8.21 M $2.13 M +$738 K +53.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 $7.48 M $2.13 M +$751 K +54.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $6.72 M $1.91 M +$578 K +43.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $6.15 M $2.05 M +$721 K +54.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-18
Q3 2013 $5.43 M $1.39 M -$13 K -0.93% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $5.44 M $1.38 M +$154 K +12.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 $5.28 M $1.33 M -$54 K -3.91% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $5.34 M $1.33 M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $1.4 M -$648 K -31.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 $1.22 M -$742 K -37.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 $1.38 M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 $2.05 M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $1.97 M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.